The optimal timing of evaluation of genebank accessions and the effect of biotechnology

The lack of ex ante evaluation of germplasm in genebanks has been the single most prevalent and long‐standing complaint of plant breeders about the management of genebanks. Advances in biotechnology offer the possibility of faster, cheaper and more efficient evaluation methodologies. Will these new...

Full description

Bibliographic Details
Main Authors: Koo, Bonwoo, Wright, Brian D.
Format: Journal Article
Language:Inglés
Published: Wiley 2000
Subjects:
Online Access:https://hdl.handle.net/10568/156633
_version_ 1855534946653831168
author Koo, Bonwoo
Wright, Brian D.
author_browse Koo, Bonwoo
Wright, Brian D.
author_facet Koo, Bonwoo
Wright, Brian D.
author_sort Koo, Bonwoo
collection Repository of Agricultural Research Outputs (CGSpace)
description The lack of ex ante evaluation of germplasm in genebanks has been the single most prevalent and long‐standing complaint of plant breeders about the management of genebanks. Advances in biotechnology offer the possibility of faster, cheaper and more efficient evaluation methodologies. Will these new technologies favor ex post evaluation, as some expect, or will they lead to more ex ante evaluation? Will they also lead to earlier development of varieties with specific traits in anticipation of demand for them? Will the prospect of further advances in biotechnology favor delay of evaluation and development? This paper addresses these questions in the case of evaluation of germplasm for resistance to a disease.
format Journal Article
id CGSpace156633
institution CGIAR Consortium
language Inglés
publishDate 2000
publishDateRange 2000
publishDateSort 2000
publisher Wiley
publisherStr Wiley
record_format dspace
spelling CGSpace1566332024-10-24T12:44:53Z The optimal timing of evaluation of genebank accessions and the effect of biotechnology Koo, Bonwoo Wright, Brian D. agriculture The lack of ex ante evaluation of germplasm in genebanks has been the single most prevalent and long‐standing complaint of plant breeders about the management of genebanks. Advances in biotechnology offer the possibility of faster, cheaper and more efficient evaluation methodologies. Will these new technologies favor ex post evaluation, as some expect, or will they lead to more ex ante evaluation? Will they also lead to earlier development of varieties with specific traits in anticipation of demand for them? Will the prospect of further advances in biotechnology favor delay of evaluation and development? This paper addresses these questions in the case of evaluation of germplasm for resistance to a disease. 2000-11 2024-10-24T12:44:53Z 2024-10-24T12:44:53Z Journal Article https://hdl.handle.net/10568/156633 en Limited Access Wiley Koo, Bonwoo; Wright, Brian D. 2000. The optimal timing of evaluation of genebank accessions and the effect of biotechnology. American Journal of Agricultural Economics 82(4): 797-811. https://doi.org/10.1111/0002-9092.00082
spellingShingle agriculture
Koo, Bonwoo
Wright, Brian D.
The optimal timing of evaluation of genebank accessions and the effect of biotechnology
title The optimal timing of evaluation of genebank accessions and the effect of biotechnology
title_full The optimal timing of evaluation of genebank accessions and the effect of biotechnology
title_fullStr The optimal timing of evaluation of genebank accessions and the effect of biotechnology
title_full_unstemmed The optimal timing of evaluation of genebank accessions and the effect of biotechnology
title_short The optimal timing of evaluation of genebank accessions and the effect of biotechnology
title_sort optimal timing of evaluation of genebank accessions and the effect of biotechnology
topic agriculture
url https://hdl.handle.net/10568/156633
work_keys_str_mv AT koobonwoo theoptimaltimingofevaluationofgenebankaccessionsandtheeffectofbiotechnology
AT wrightbriand theoptimaltimingofevaluationofgenebankaccessionsandtheeffectofbiotechnology
AT koobonwoo optimaltimingofevaluationofgenebankaccessionsandtheeffectofbiotechnology
AT wrightbriand optimaltimingofevaluationofgenebankaccessionsandtheeffectofbiotechnology